|
G |
PLCG1 |
phospholipase C gamma 1 |
decreases activity multiple interactions |
EXP |
1,2-Dipalmitoylphosphatidylcholine results in decreased activity of PLCG1 protein dipalmitoylphosphatidic acid inhibits the reaction [1,2-Dipalmitoylphosphatidylcholine results in decreased activity of PLCG1 protein] |
CTD |
PMID:2001791 |
|
NCBI chr24:29,198,536...29,213,899
Ensembl chr24:29,198,556...29,214,714
|
|
|
G |
PLCG1 |
phospholipase C gamma 1 |
increases activity |
EXP |
1-stearoyl-2-arachidonoylphosphatidic acid results in increased activity of PLCG1 protein |
CTD |
PMID:2001791 |
|
NCBI chr24:29,198,536...29,213,899
Ensembl chr24:29,198,556...29,214,714
|
|
|
G |
HIF1A |
hypoxia inducible factor 1 subunit alpha |
increases expression |
EXP |
15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of HIF1A protein |
CTD |
PMID:17658243 |
|
NCBI chr 8:36,614,045...36,656,692
Ensembl chr 8:36,614,045...36,656,692
|
|
|
G |
SCT |
secretin |
decreases abundance |
EXP |
SCT protein results in decreased abundance of Lactic Acid |
CTD |
PMID:2418308 |
|
|
|
|
G |
ACHE |
acetylcholinesterase |
multiple interactions |
EXP |
[Obidoxime Chloride co-treated with Atropine] inhibits the reaction [Sarin results in decreased activity of ACHE protein]; [Obidoxime Chloride co-treated with Atropine] inhibits the reaction [Soman results in decreased activity of ACHE protein]; [Obidoxime Chloride co-treated with Atropine] inhibits the reaction [VX results in decreased activity of ACHE protein] |
CTD |
PMID:16915560 |
|
NCBI chr 6:8,874,747...8,879,926
Ensembl chr 6:8,873,584...8,879,702
|
|
G |
SCT |
secretin |
multiple interactions |
EXP |
Atropine inhibits the reaction [SCT protein results in increased abundance of Bicarbonates] |
CTD |
PMID:3562434 |
|
|
|
|
G |
ACAA2 |
acetyl-CoA acyltransferase 2 |
increases expression |
EXP |
Clofibrate results in increased expression of ACAA2 mRNA |
CTD |
PMID:19952500 |
|
NCBI chr 7:79,028,636...79,057,720
|
|
G |
ACADVL |
acyl-CoA dehydrogenase very long chain |
increases expression |
EXP |
Clofibrate results in increased expression of ACADVL protein |
CTD |
PMID:19952500 |
|
NCBI chr 5:32,189,191...32,194,255
Ensembl chr 5:32,186,502...32,327,990
|
|
G |
AGXT |
alanine--glyoxylate and serine--pyruvate aminotransferase |
decreases expression |
EXP |
Clofibrate results in decreased expression of AGXT protein |
CTD |
PMID:19952500 |
|
NCBI chr25:50,968,291...50,976,089
|
|
G |
AHCY |
adenosylhomocysteinase |
decreases expression |
EXP |
Clofibrate results in decreased expression of AHCY protein |
CTD |
PMID:19952500 |
|
NCBI chr24:23,410,553...23,423,494
Ensembl chr24:23,411,140...23,419,767
|
|
G |
ASL |
argininosuccinate lyase |
increases expression |
EXP |
Clofibrate results in increased expression of ASL protein |
CTD |
PMID:19952500 |
|
NCBI chr 6:768,522...779,144
Ensembl chr 6:730,358...779,424
|
|
G |
ASS1 |
argininosuccinate synthase 1 |
decreases expression |
EXP |
Clofibrate results in decreased expression of ASS1 protein |
CTD |
PMID:19952500 |
|
NCBI chr 9:53,425,228...53,478,007
Ensembl chr 9:53,425,448...53,477,904
|
|
G |
CPS1 |
carbamoyl-phosphate synthase 1 |
increases expression |
EXP |
Clofibrate results in increased expression of CPS1 protein |
CTD |
PMID:19952500 |
|
NCBI chr37:18,308,164...18,428,487
Ensembl chr37:18,143,986...18,427,697
|
|
G |
CPT2 |
carnitine palmitoyltransferase 2 |
increases expression |
EXP |
Clofibrate results in increased expression of CPT2 mRNA |
CTD |
PMID:19952500 |
|
NCBI chr 5:55,718,209...55,786,175
Ensembl chr 5:55,718,510...55,744,809
|
|
G |
CYP1A2 |
cytochrome P450 family 1 subfamily A member 2 |
decreases expression |
EXP |
Clofibrate results in decreased expression of CYP1A2 mRNA |
CTD |
PMID:19952500 |
|
NCBI chr30:37,818,400...37,824,192
Ensembl chr30:37,799,140...37,824,135
|
|
G |
CYP2A13 |
cytochrome P450 family 2 subfamily A polypeptide 13 |
decreases expression |
EXP |
Clofibrate results in decreased expression of CYP2A13 mRNA |
CTD |
PMID:19952500 |
|
NCBI chr 1:112,932,246...112,938,248
Ensembl chr 1:112,931,985...112,938,350
|
|
G |
CYP2B6 |
cytochrome P450 2B11 |
decreases expression |
EXP |
Clofibrate results in decreased expression of CYP2B6 mRNA |
CTD |
PMID:19952500 |
|
NCBI chr 1:112,817,561...112,833,294
Ensembl chr 1:112,816,502...112,833,293
|
|
G |
CYP2C18 |
cytochrome P450 2C21 |
decreases expression |
EXP |
Clofibrate results in decreased expression of CYP2C18 mRNA |
CTD |
PMID:19952500 |
|
NCBI chr28:8,727,010...8,750,427
Ensembl chr28:8,727,019...8,750,587
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
increases expression |
EXP |
Clofibrate results in increased expression of CYP2E1 protein |
CTD |
PMID:19952500 |
|
NCBI chr28:41,079,164...41,089,188
Ensembl chr28:41,035,025...41,122,754
|
|
G |
CYP3A12 |
cytochrome P-450 3A12 |
decreases expression |
EXP |
Clofibrate results in decreased expression of CYP3A12 mRNA |
CTD |
PMID:19952500 |
|
|
|
G |
CYP3A26 |
cytochrome P450 3A26 |
decreases expression |
EXP |
Clofibrate results in decreased expression of CYP3A26 mRNA |
CTD |
PMID:19952500 |
|
NCBI chr 6:9,777,663...9,815,345
Ensembl chr 6:9,777,659...9,869,352
|
|
G |
CYP4A37 |
cytochrome P450 4A37 |
increases expression |
EXP |
Clofibrate results in increased expression of CYP4A11 mRNA |
CTD |
PMID:19952500 |
|
NCBI chr15:13,604,130...13,623,797
|
|
G |
DLST |
dihydrolipoamide S-succinyltransferase |
increases expression |
EXP |
Clofibrate results in increased expression of DLST protein |
CTD |
PMID:19952500 |
|
NCBI chr 8:48,003,730...48,025,001
Ensembl chr 8:48,002,211...48,024,999
|
|
G |
ECHS1 |
enoyl-CoA hydratase, short chain 1 |
increases expression |
EXP |
Clofibrate results in increased expression of ECHS1 protein |
CTD |
PMID:19952500 |
|
NCBI chr28:40,939,856...40,947,694
Ensembl chr28:40,939,961...40,946,167
|
|
G |
GDI1 |
GDP dissociation inhibitor 1 |
increases expression |
EXP |
Clofibrate results in increased expression of GDI1 protein |
CTD |
PMID:19952500 |
|
NCBI chr X:122,141,633...122,146,724
Ensembl chr X:122,141,566...122,146,824
|
|
G |
GSTA4 |
glutathione S-transferase alpha 4 |
decreases expression |
EXP |
Clofibrate results in decreased expression of GSTA4 mRNA |
CTD |
PMID:19952500 |
|
NCBI chr12:20,426,724...20,443,200
Ensembl chr12:20,426,726...20,443,200
|
|
G |
GSTK1 |
glutathione S-transferase kappa 1 |
decreases expression |
EXP |
Clofibrate results in decreased expression of GSTK1 mRNA |
CTD |
PMID:19952500 |
|
NCBI chr16:6,411,678...6,416,135
|
|
G |
GSTO1 |
glutathione S-transferase omega 1 |
decreases expression |
EXP |
Clofibrate results in decreased expression of GSTO1 mRNA |
CTD |
PMID:19952500 |
|
NCBI chr28:16,569,421...16,579,239
Ensembl chr28:16,569,066...16,619,880
|
|
G |
HADH |
hydroxyacyl-CoA dehydrogenase |
increases expression |
EXP |
Clofibrate results in increased expression of HADH mRNA |
CTD |
PMID:19952500 |
|
NCBI chr32:28,460,445...28,506,141
Ensembl chr32:28,460,193...28,531,280
|
|
G |
HSPD1 |
heat shock protein family D (Hsp60) member 1 |
increases expression |
EXP |
Clofibrate results in increased expression of HSPD1 protein |
CTD |
PMID:19952500 |
|
NCBI chr37:7,010,421...7,025,912
|
|
G |
KRT1 |
keratin 1 |
increases expression |
EXP |
Clofibrate results in increased expression of KRT1 protein |
CTD |
PMID:19952500 |
|
NCBI chr27:2,422,150...2,427,160
|
|
G |
KRT18 |
keratin 18 |
decreases expression |
EXP |
Clofibrate results in decreased expression of KRT18 protein |
CTD |
PMID:19952500 |
|
NCBI chr27:2,189,269...2,193,368
Ensembl chr27:2,189,269...2,193,368
|
|
G |
LOC474938 |
glutathione S-transferase A2 |
decreases expression |
EXP |
Clofibrate results in decreased expression of GSTA3 mRNA; Clofibrate results in decreased expression of GSTA3 protein |
CTD |
PMID:19952500 |
|
NCBI chr12:20,349,133...20,365,023
|
|
G |
MGST1 |
microsomal glutathione S-transferase 1 |
increases expression |
EXP |
Clofibrate results in increased expression of MGST1 mRNA |
CTD |
PMID:19952500 |
|
NCBI chr27:30,370,588...30,391,898
Ensembl chr27:30,370,594...30,391,778
|
|
G |
PC |
pyruvate carboxylase |
increases expression |
EXP |
Clofibrate results in increased expression of PC protein |
CTD |
PMID:19952500 |
|
NCBI chr18:50,406,994...50,507,677
Ensembl chr18:50,412,272...50,507,669
|
|
G |
PCK2 |
phosphoenolpyruvate carboxykinase 2, mitochondrial |
increases expression |
EXP |
Clofibrate results in increased expression of PCK2 protein |
CTD |
PMID:19952500 |
|
NCBI chr 8:4,099,016...4,107,870
Ensembl chr 8:4,098,671...4,107,865
|
|
G |
PRDX6 |
peroxiredoxin 6 |
decreases expression |
EXP |
Clofibrate results in decreased expression of PRDX6 protein |
CTD |
PMID:19952500 |
|
NCBI chr 7:25,663,238...25,675,855
Ensembl chr 7:25,663,579...25,675,754
|
|
G |
SELENBP1 |
selenium binding protein 1 |
decreases expression |
EXP |
Clofibrate results in decreased expression of SELENBP1 protein |
CTD |
PMID:19952500 |
|
NCBI chr17:60,410,727...60,418,770
Ensembl chr17:60,410,734...60,418,704
|
|
G |
SHMT1 |
serine hydroxymethyltransferase 1 |
decreases expression |
EXP |
Clofibrate results in decreased expression of SHMT1 protein |
CTD |
PMID:19952500 |
|
NCBI chr 5:41,221,531...41,248,653
Ensembl chr 5:41,221,562...41,253,166
|
|
G |
UGP2 |
UDP-glucose pyrophosphorylase 2 |
decreases expression |
EXP |
Clofibrate results in decreased expression of UGP2 protein |
CTD |
PMID:19952500 |
|
NCBI chr10:63,532,366...63,598,362
Ensembl chr10:63,533,171...63,597,452
|
|
G |
UQCRC1 |
ubiquinol-cytochrome c reductase core protein 1 |
increases expression |
EXP |
Clofibrate results in increased expression of UQCRC1 protein |
CTD |
PMID:19952500 |
|
NCBI chr20:40,507,767...40,515,854
Ensembl chr20:40,506,907...40,520,110
|
|
G |
UROC1 |
urocanate hydratase 1 |
decreases expression |
EXP |
Clofibrate results in decreased expression of UROC1 protein |
CTD |
PMID:19952500 |
|
NCBI chr20:676,624...717,109
Ensembl chr20:678,073...717,141
|
|
|
G |
PLCG1 |
phospholipase C gamma 1 |
multiple interactions increases activity |
EXP |
dipalmitoylphosphatidic acid inhibits the reaction [1,2-Dipalmitoylphosphatidylcholine results in decreased activity of PLCG1 protein] dipalmitoylphosphatidic acid results in increased activity of PLCG1 protein |
CTD |
PMID:2001791 |
|
NCBI chr24:29,198,536...29,213,899
Ensembl chr24:29,198,556...29,214,714
|
|
|
G |
PTGS1 |
prostaglandin-endoperoxide synthase 1 |
decreases activity |
EXP |
Ibuprofen results in decreased activity of PTGS1 protein alternative form |
CTD |
PMID:12242329 |
|
NCBI chr 9:60,195,118...60,216,847
Ensembl chr 9:60,195,124...60,216,819
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
increases expression |
EXP |
Ibuprofen results in increased expression of PTGS2 protein |
CTD |
PMID:16105799 |
|
NCBI chr 7:19,668,079...19,674,903
Ensembl chr 7:19,668,082...19,674,903
|
|
|
G |
INS |
insulin |
multiple interactions |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK1 protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK3 protein]; [Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK1 protein; [Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:12639917 |
|
NCBI chr18:46,324,047...46,324,933
Ensembl chr18:46,324,041...46,325,122
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK1 protein]; [Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:12639917 |
|
NCBI chr26:31,013,607...31,132,998
Ensembl chr26:31,013,607...31,132,998
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK3 protein]; [Tetradecanoylphorbol Acetate co-treated with INS protein] results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:12639917 |
|
NCBI chr 6:18,109,184...18,115,728
Ensembl chr 6:18,109,222...18,114,425
|
|
G |
SLC6A9 |
solute carrier family 6 member 9 |
multiple interactions affects localization |
EXP |
Tetradecanoylphorbol Acetate promotes the reaction [Monensin affects the localization of SLC6A9 protein] Tetradecanoylphorbol Acetate affects the localization of SLC6A9 protein |
CTD |
PMID:19473961 |
|
NCBI chr15:16,235,342...16,267,161
Ensembl chr15:16,235,482...16,267,933
|
|
G |
SOD1 |
superoxide dismutase 1 |
affects response to substance |
EXP |
SOD1 protein affects the susceptibility to Tetradecanoylphorbol Acetate |
CTD |
PMID:6333936 |
|
NCBI chr31:26,540,291...26,544,212
Ensembl chr31:26,486,274...26,662,815
|
|
|
G |
REN |
renin |
increases expression |
EXP |
Dinoprostone results in increased expression of REN protein |
CTD |
PMID:495730 |
|
NCBI chr38:744,540...766,998
Ensembl chr38:744,614...755,012
|
|
|
G |
SCT |
secretin |
decreases abundance |
EXP |
SCT protein results in decreased abundance of Lactic Acid |
CTD |
PMID:2418308 |
|
|
|
|
G |
NOS3 |
nitric oxide synthase 3 |
increases expression decreases expression |
EXP |
Simvastatin results in increased expression of NOS3 protein Simvastatin results in decreased expression of NOS3 mRNA |
CTD |
PMID:11087217 |
|
NCBI chr16:15,054,196...15,072,454
Ensembl chr16:15,011,344...15,072,277
|
|
|
G |
CPNE6 |
copine 6 |
decreases activity |
EXP |
Myristic Acid results in decreased activity of DHRS4 protein |
CTD |
PMID:17827741 |
|
NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
|
|
|
G |
HSPA5 |
heat shock protein family A (Hsp70) member 5 |
increases expression |
EXP |
Thapsigargin results in increased expression of HSPA5 protein |
CTD |
PMID:17416481 |
|
NCBI chr 9:57,850,870...57,855,607
Ensembl chr 9:57,850,922...57,855,257
|
|
|
G |
ACHE |
acetylcholinesterase |
multiple interactions |
EXP |
[Obidoxime Chloride co-treated with Atropine] inhibits the reaction [Sarin results in decreased activity of ACHE protein]; [Obidoxime Chloride co-treated with Atropine] inhibits the reaction [Soman results in decreased activity of ACHE protein]; [Obidoxime Chloride co-treated with Atropine] inhibits the reaction [VX results in decreased activity of ACHE protein] |
CTD |
PMID:16915560 |
|
NCBI chr 6:8,874,747...8,879,926
Ensembl chr 6:8,873,584...8,879,702
|
|
G |
SCT |
secretin |
multiple interactions |
EXP |
Atropine inhibits the reaction [SCT protein results in increased abundance of Bicarbonates] |
CTD |
PMID:3562434 |
|
|
|
|
G |
CPNE6 |
copine 6 |
decreases activity |
EXP |
Valproic Acid results in decreased activity of DHRS4 protein |
CTD |
PMID:17827741 |
|
NCBI chr 8:4,046,532...4,058,498
Ensembl chr 8:4,046,544...4,084,744
|
|